From: Shared decision-making in antihypertensive therapy: a cluster randomised controlled trial
Characteristics at T0 | Intervention group | Control group |
---|---|---|
(N =552) | (N = 568) | |
Age mean (SD) | 63.8 (± 12.1) | 65.0 (± 12.4) |
Gender: male % (N) | 46.7% (258) | 44.7% (254) |
Educational level (Total valid N) | (523) | (521) |
low | 62.7% (328) | 63.8% (332) |
middle | 24.1% (126) | 22.6% (118) |
high | 13.2% (69) | 13.6% (71) |
ABDM (Total valid N) | (552) | (568) |
24h-mean systolic (SD) | 133.19 (13.58) | 130.80 (12.62) |
24h-mean diastolic (SD) | 81.98 (9.77) | 79.29 (9.74) |
Uncontrolled hypertension | 90.8% (501) | 84.7% (481) |
≥ 1 Comorbidity | 41.1% (227) | 48.8% (277) |
Diabetes mellitus | 23.7% (131) | 32.6% (185) |
Heart attack / CHD | 16.8% (93) | 20.8% (118) |
Stroke/ TIA | 4.7% (26) | 5.5% (31) |
Peripheral arterial occlusive disease | 3.6% (20) | 4.1% (23) |
Manifest arteriosclerosis (heart attack, CHD, stroke, TIA, or PAOD) | 22.6% (125) | 26.4% (150) |
CVR score in % (Total valid N) | (420) | (377) |
Mean (SD) | 20.40 (± 19.1) | 22.85 (± 18.71) |
BMI (Total valid N) | (545) | (561) |
Mean (SD) | 28.58 (± 4.78) | 28.58 (± 4.79) |
Smoking (Total valid N) | (544) | (558) |
Positive (N) | 11.2% (861) | 11.6% (65) |
Family history of CVD (Total valid N) | (528) | (527) |
Positive (N) | 24.2% (128) | 19.4% (102) |
Treatment outside the GP praxis | 35.3% (195) | 35.0% (199) |
SDM-Q-9* (Total valid N) | (451) | (489) |
Mean (SD) | 73.00 (± 17.66) | 70.67 (± 20.24) |
Intention-to-treat-hypertension scale* (Total valid N) | (521) | (527) |
Mean (SD) | 80.61 (± 13.32) | 79.79 (± 13.52) |
MARS-D*(Total valid N) | (531) | (539) |
Mean (SD) | 93.9 (± 9.8) | 93.5 (± 10.1) |
Knowledge* (Total valid N) | (536) | (547) |
Mean (SD) | 46.63 (± 27.60) | 44.22 (± 28.64) |